Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 May;142(5):1383–1391.

Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.

K Nakamura 1, N Murase 1, M J Becich 1, T Furuya 1, S Todo 1, J J Fung 1, T E Starzl 1, A J Demetris 1
PMCID: PMC1886908  PMID: 8494042

Abstract

A sequential analysis of liver allograft rejection in sensitized rats using immunopathological and ultrastructural microscopy is described. Lewis rats were primed with four ACI skin grafts and challenged with an arterialized ACI orthotopic liver allograft 14 to 17 weeks later. The sensitization resulted in a mix of IgG and IgM lymphocytotoxic antibodies at a titer of 1:512 at the time of transplantation. Specificity analysis of pretransplant immune sera revealed a predominance of IgG anti-class I major histocompatibility complex (RT1) antibodies with a minor IgG fraction showing apparent endothelial cell specificity (non-RT1). This level of sensitization was associated with accelerated graft failure in 3 to 5 days from mixed humoral and cellular rejection. Sequential analysis of serial posttransplant graft biopsies revealed diffuse vascular IgG deposition and platelet thrombi in portal veins and periportal sinusoids within 3 minutes after reperfusion. This was followed by endothelial cell hypertrophy and vacuolization, periportal hepatocyte necrosis, arterial spasm, focal large bile duct necrosis, and hilar mast cell infiltration and degranulation. However, the liver allografts did not fail precipitously and hyperacute rejection was not seen. Kupffer cell phagocytosis of the sinusoidal platelets began as early as 30 minutes posttransplant and by 24 hours, the platelet thrombi had decreased. Cholangioles appeared focally at the edge of the limiting plates by 2 to 3 days, apparently in response to earlier periportal hepatocyte damage. A mononuclear portal and perivenular infiltrate became evident at 3 days, and graft failure was attributed to both antibody and cell-mediated rejection (Furuya et al: Preformed lymphocytotoxic antibodies: Hepatology 1992, 16: 1415-1422). The model described resembles observations in crossmatch positive human liver allograft recipients. The mechanisms of hepatic graft resistance to antibody mediated rejection and the possible long term consequences of early damage to the biliary tree are discussed.

Full text

PDF
1383

Images in this article

1386Figure 1
on p.1386
1387Figure 2
on p.1387
1387Figure 3
on p.1387
1387Figure 4
on p.1387
1388Figure 5
on p.1388
1388Figure 6
on p.1388
1388Figure 7
on p.1388
1389Figure 8
on p.1389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batts K. P., Moore S. B., Perkins J. D., Wiesner R. H., Grambsch P. M., Krom R. A. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation. 1988 Feb;45(2):376–379. doi: 10.1097/00007890-198802000-00026. [DOI] [PubMed] [Google Scholar]
  2. Billiar T. R., Curran R. D., Harbrecht B. G., Stuehr D. J., Demetris A. J., Simmons R. L. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol. 1990 Dec;48(6):565–569. doi: 10.1002/jlb.48.6.565. [DOI] [PubMed] [Google Scholar]
  3. Bird G., Friend P., Donaldson P., O'Grady J., Portmann B., Calne R., Williams R. Hyperacute rejection in liver transplantation: a case report. Transplant Proc. 1989 Aug;21(4):3742–3744. [PubMed] [Google Scholar]
  4. Davies H. S., Pollard S. G., Calne R. Y. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 1989 Mar;47(3):524–527. doi: 10.1097/00007890-198903000-00025. [DOI] [PubMed] [Google Scholar]
  5. Demetris A. J., Jaffe R., Tzakis A., Ramsey G., Todo S., Belle S., Esquivel C., Shapiro R., Markus B., Mroczek E. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol. 1988 Sep;132(3):489–502. [PMC free article] [PubMed] [Google Scholar]
  6. Demetris A. J., Nakamura K., Yagihashi A., Iwaki Y., Takaya S., Hartman G. G., Murase N., Bronsther O., Manez R., Fung J. J. A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology. 1992 Sep;16(3):671–681. doi: 10.1002/hep.1840160310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Donaldson P. T., Alexander G. J., O'Grady J., Neuberger J., Portmann B., Thick M., Davis H., Calne R. Y., Williams R. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet. 1987 Apr 25;1(8539):945–951. doi: 10.1016/s0140-6736(87)90293-5. [DOI] [PubMed] [Google Scholar]
  8. Forbes R. D., Kuramochi T., Guttmann R. D., Klassen J., Knaack J. A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat. Lab Invest. 1975 Sep;33(3):280–288. [PubMed] [Google Scholar]
  9. Furuya T., Murase N., Nakamura K., Woo J., Todo S., Demetris A. J., Starzl T. E. Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology. 1992 Dec;16(6):1415–1422. doi: 10.1002/hep.1840160618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galli S. J. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 1990 Jan;62(1):5–33. [PubMed] [Google Scholar]
  11. Gubernatis G., Lauchart W., Jonker M., Steinhoff G., Bornscheuer A., Neuhaus P., van Es A. A., Kemnitz J., Wonigeit K., Pichlmayr R. Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc. 1987 Feb;19(1 Pt 2):1082–1083. [PubMed] [Google Scholar]
  12. Gugenheim J., Le Thai B., Rouger P., Gigou M., Gane P., Vial M. C., Charpentier B., Reynes M., Bismuth H. Relationship between the liver and lymphocytotoxic alloantibodies in inbred rats. Specific absorption by nonparenchymal liver cells. Transplantation. 1988 Feb;45(2):474–478. doi: 10.1097/00007890-198802000-00046. [DOI] [PubMed] [Google Scholar]
  13. Guttmann R. D. Genetics of acute rejection of rat cardiac allografts and a model of hyperacute rejection. Transplantation. 1974 Apr;17(4):383–386. doi: 10.1097/00007890-197404000-00007. [DOI] [PubMed] [Google Scholar]
  14. Houssin D., Bellon B., Brunaud M. D., Gugenheim J., Settaf A., Meriggi F., Emond J. Interactions between liver allografts and lymphocytotoxic alloantibodies in inbred rats. Hepatology. 1986 Sep-Oct;6(5):994–998. doi: 10.1002/hep.1840060531. [DOI] [PubMed] [Google Scholar]
  15. Kakizoe S., Yanaga K., Starzl T. E., Demetris A. J. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology. 1990 Jun;11(6):932–941. doi: 10.1002/hep.1840110605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kamada N., Calne R. Y. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation. 1979 Jul;28(1):47–50. [PubMed] [Google Scholar]
  17. Knechtle S. J., Kolbeck P. C., Tsuchimoto S., Coundouriotis A., Sanfilippo F., Bollinger R. R. Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. Transplantation. 1987 Jan;43(1):8–12. doi: 10.1097/00007890-198701000-00003. [DOI] [PubMed] [Google Scholar]
  18. Makowka L., Miller C., Chapchap P., Podesta L., Pan C., Pressley D., Mazzaferro V., Esquivel C. O., Todo S., Banner B. Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg. 1987 Oct;206(4):482–495. doi: 10.1097/00000658-198710000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sanchez-Urdazpal L., Sterioff S., Janes C., Schwerman L., Rosen C., Krom R. A. Increased bile duct complications in ABO incompatible liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1440–1441. [PubMed] [Google Scholar]
  20. Takaya S., Bronsther O., Iwaki Y., Nakamura K., Abu-Elmagd K., Yagihashi A., Demetris A. J., Kobayashi M., Todo S., Tzakis A. G. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation. 1992 Feb;53(2):400–406. doi: 10.1097/00007890-199202010-00026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Takaya S., Duquesnoy R., Iwaki Y., Demetris J., Yagihashi A., Bronsther O., Iwatsuki S., Starzl T. E. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc. 1991 Feb;23(1 Pt 1):396–399. [PMC free article] [PubMed] [Google Scholar]
  22. Terasaki P. I., Bernoco D., Park M. S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. doi: 10.1093/ajcp/69.2.103. [DOI] [PubMed] [Google Scholar]
  23. Wardle E. N. Kupffer cells and their function. Liver. 1987 Apr;7(2):63–75. doi: 10.1111/j.1600-0676.1987.tb00319.x. [DOI] [PubMed] [Google Scholar]
  24. Weber T., Marino I. R., Kang Y. G., Esquivel C. D., Starzl T. E., Duquesnoy R. J. Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation. 1989 May;47(5):797–801. doi: 10.1097/00007890-198905000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES